These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Results of treatment in new cases of pulmonary tuberculosis registered in 1963 at the Antitubercular Dispensary of the Wola District of Warsaw]. Rose A Gruzlica; 1967 Dec; 35(12):1251-6. PubMed ID: 6081907 [No Abstract] [Full Text] [Related]
46. [Problems caused by circumscribed caseous pulmonary tuberculosis in the antitubercular dispensary]. Bucur D; Szima Z Ftiziologia; 1971; 20(6):615-8. PubMed ID: 5162287 [No Abstract] [Full Text] [Related]
47. Tuberculosis in the elderly: treating the "white plague". Iseman MD Geriatrics; 1980 Mar; 35(3):90-107. PubMed ID: 7353794 [No Abstract] [Full Text] [Related]
48. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208 [TBL] [Abstract][Full Text] [Related]
49. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis. Gourevitch MN; Alcabes P; Wasserman WC; Arno PS Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818 [TBL] [Abstract][Full Text] [Related]
50. [Chemotherapy effectiveness in destructive pulmonary tuberculosis in the middle-aged and elderly using different methods of administering the preparations]. Abrarov BA; Tursunov FI; Leĭbzon IuN; Slobodskoĭ SA; Arifov SA Probl Tuberk; 1982 Mar; (3):34-7. PubMed ID: 7088920 [No Abstract] [Full Text] [Related]
51. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548 [No Abstract] [Full Text] [Related]
52. [The chemoprophylaxis of tuberculosis]. Murriev A Med Sestra; 1990 Nov; 49(11):39-42. PubMed ID: 2074744 [No Abstract] [Full Text] [Related]
53. Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in aboriginal peoples in British Columbia. Heal G; Elwood RK; FitzGerald JM Int J Tuberc Lung Dis; 1998 Dec; 2(12):979-83. PubMed ID: 9869112 [TBL] [Abstract][Full Text] [Related]
54. The pathogenesis and treatment of isoniazid-resistant tuberculosis in 13 patients. Greenberg HB J La State Med Soc; 1969 Dec; 121(12):381-5. PubMed ID: 5368395 [No Abstract] [Full Text] [Related]
55. Developments in the national tuberculosis control programme in Tanzania. Nkinda SJ; Mulder DW; Styblo K Bull Int Union Tuberc; 1984; 59(1-2):77-84. PubMed ID: 6509227 [No Abstract] [Full Text] [Related]
56. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. Mok MY; Lo Y; Chan TM; Wong WS; Lau CS J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014 [TBL] [Abstract][Full Text] [Related]
57. Isoniazid chemoprophylaxis for dual HIV-TB infection: a cautionary tale. FitzGerald JM Can Commun Dis Rep; 1995 Feb; 21(4):29-32; discussion 32, 35. PubMed ID: 7735192 [No Abstract] [Full Text] [Related]
58. Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime. Nolan CM Am J Respir Crit Care Med; 2003 Aug; 168(4):412-3. PubMed ID: 12912731 [No Abstract] [Full Text] [Related]
59. [Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results]. Cornudella R; Garcia-Besada JA; Castellano A Rev Clin Esp; 1972 Jul; 126(1):59-64. PubMed ID: 5080189 [No Abstract] [Full Text] [Related]